RCEL logo

RCEL
AVITA Medical Inc

1,135
Mkt Cap
$139.07M
Volume
291,705.00
52W High
$10.29
52W Low
$3.22
PE Ratio
-2.86
RCEL Fundamentals
Price
$5.01
Prev Close
$4.54
Open
$4.60
50D MA
$4.35
Beta
1.53
Avg. Volume
201,454.96
EPS (Annual)
-$1.74
P/B
-9.20
Rev/Employee
$316,858.41
$123.98
Loading...
Loading...
News
all
press releases
Avita Medical (NASDAQ:RCEL) Given Buy Rating at D. Boral Capital
D. Boral Capital restated a "buy" rating and issued a $10.00 target price on shares of Avita Medical in a research note on Wednesday...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Analysts
Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) has earned an average rating of "Hold" from the six ratings firms that are currently covering the firm, MarketBeat.com reports. One equities...
MarketBeat·20d ago
News Placeholder
Northland Securities Predicts Avita Medical Q1 Earnings
Avita Medical Inc. (NASDAQ:RCEL - Free Report) - Equities research analysts at Northland Securities issued their Q1 2026 earnings estimates for Avita Medical in a research note issued on Thursday...
MarketBeat·1mo ago
News Placeholder
Avita Medical (NASDAQ:RCEL) Now Covered by Analysts at Northland Securities
Northland Securities began coverage on shares of Avita Medical in a research note on Thursday. They set an "outperform" rating and a $10.00 target price on the stock...
MarketBeat·1mo ago
News Placeholder
Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade
The consensus price target hints at a 29.9% upside potential for Avita Medical (RCEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·1mo ago
News Placeholder
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Rating of "Hold" by Analysts
Shares of Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) have been given a consensus rating of "Hold" by the five research firms that are presently covering the firm, Marketbeat.com reports. One...
MarketBeat·2mo ago
News Placeholder
Avita Medical Targets Progressive 2026 Growth, Guides $80M-$85M Revenue After Headwind Year
Avita Medical (NASDAQ:RCEL) executives told investors they are focused on making the business more predictable and execution-driven in 2026, following what they described as a headwind-heavy 2025...
MarketBeat·2mo ago
News Placeholder
Insider Buying: Avita Medical (NASDAQ:RCEL) CFO Acquires 3,000 Shares of Stock
Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) CFO David O'toole purchased 3,000 shares of the stock in a transaction dated Thursday, February 19th. The stock was purchased at an average price of...
MarketBeat·2mo ago
News Placeholder
Avita Medical (NASDAQ:RCEL) CFO David O'toole Purchases 3,000 Shares of Stock
Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) CFO David O'toole acquired 3,000 shares of the business's stock in a transaction dated Thursday, February 19th. The stock was purchased at an...
MarketBeat·2mo ago
News Placeholder
Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know
Avita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·2mo ago
<
1
2
...
>

Latest RCEL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.